Navigation Links
Age-related hearing loss and folate in the elderly
Date:12/1/2010

Alexandria, VA Age-related hearing loss (ARHL), one of the four most prevalent chronic conditions in the elderly, is associated with low serum levels of folic acid, according to new research published in the December 2010 issue of Otolaryngology Head and Neck Surgery.

Hearing loss is a major public health problem globally, with more than 28 million Americans between the ages of 60 and 74 dealing with the loss. Despite the high prevalence of hearing impairment, the biological basis of age-related hearing loss is unknown. In the current study, findings show that low serum levels of folic acid among elderly people are significantly associated with hearing loss in high frequencies.

"Based on our research, age-related hearing loss may be associated with poor micronutrient status. The role of folate in cellular metabolism, the nervous system, and vascular function are important for the auditory system," said study author Akeem Olawale Lasisi, MBChB, FWACS, FMCORL.

The study included face-to-face interviews with 126 elderly Nigerian men and women above 60 years old who had no known medical conditions and had been examined by physicians. The study excluded those who were found to have a history of diabetes, stroke, hypertension, ear diseases, ear infections, ear trauma, ear surgery, or exposure to noise and ototoxic drugs such as aminoglycosides, antibiotics, and diuretics.

The main finding of the study was that low serum levels of folic acid were significantly associated with high-frequency hearing loss in the elderly. In medically underserved populations like that in the study, relatively low levels of vitamin intake can be expected. That suggests a need, say the authors, for continuing study into the role of vitamins in auditory function, particularly in developing countries where malnutrition is rife.


'/>"/>

Contact: Mary Stewart
mstewart@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

Page: 1

Related biology news :

1. Genes that control cell death fingered in age-related hearing loss
2. House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss
3. Results from trials of DHA in Alzheimers disease and age-related cognitive decline
4. Blue light-filtering increases macular pigment, may protect against age-related vision loss
5. New research findings may help stop age-related macular degeneration at the molecular level
6. Compound in celery, peppers reduces age-related memory deficits
7. OGI invests in personalized medicine for age-related macular degeneration
8. A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss
9. Feeling your words: Hearing with your face
10. Diminuendo -- New mouse model for understanding cause of progressive hearing loss
11. Study offers clues to beating hearing loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: